Italia markets open in 37 minutes

PCAS SA (0NF7.L)

LSE - LSE Prezzo differito. Valuta in EUR.
Aggiungi a watchlist
12,88-5,43 (-29,64%)
Alla chiusura: 12:29PM GMT
Schermo intero
Chiusura precedente18,30
Aperto12,88
Denaro0,00 x N/D
Lettera0,00 x N/D
Min-Max giorno12,88 - 12,88
Intervallo di 52 settimane12,88 - 12,88
Volume75.000
Media VolumeN/D
CapitalizzazioneN/D
Beta (5 anni mensile)0,51
Rapporto PE (ttm)N/D
EPS (ttm)-2,95
Prossima data utiliN/D
Rendimento e dividendo (forward)N/D (N/D)
Data ex dividendoN/D
Stima target 1AN/D
  • GlobeNewswire

    PCAS: appointment of a new Chairman

    + Ecully, November 28, 2022 APPOINTMENT OF A NEW CHAIRMAN At its meeting of November 28, 2022, the PCAS Board of Directors formally acknowledged the resignation of Mr. Philippe Clavel as Chief Executive Officer of PCAS. The Board of Directors thanked Mr. Philippe Clavel for his collaboration with PCAS Group. Consequently, the Board of Directors decided to appoint Mr. Jean-Louis Martin as Chief Executive Officer of PCAS. Mr. Jean-Louis Martin, currently Vice President Human Resources and Industri

  • GlobeNewswire

    PCAS: NET SALES AS OF SEPTEMBER 30, 2022

    Ecully, November 3, 2022 NET SALES AS OF SEPTEMBER 30, 2022 PCAS (Euronext Paris: PCA), a specialist in developing and producing complex molecules for life sciences and innovative technologies, has announced the publication of its consolidated net sales as of September 30, 2022. The PCAS Group has generated consolidated net sales of €156.1 million as of September 30, 2022, a 9.6% increase compared to the same period during the previous financial year (+7.1% at constant exchange rates). In millio

  • GlobeNewswire

    1st HALF 2022 EARNINGS REPORT

    Ecully, September 8, 2022 1st HALF 2022 EARNINGS REPORT PCAS (Euronext Paris: PCA), a specialist in the development and production of complex molecules for life sciences and innovative technologies, announces the publication of its consolidated earnings for the first half of 2022. 30 June 2021 30 June 2022 in millions of euros Net sales 106.3 109.8 EBITDA (*) 8.0 -0.5 EBITDA margin 7.5% -0.5% Current operating income (*) -2.6 -15.3 Other operating income and expenses -0.4 -14.7 Operating income